Search Within

David H Ilson

Formats
  1. Journal Article (210)
  2. Meeting Abstract (169)
  3. Book Section (20)
  4. Review (14)
  5. Editorial (9)
  6. Conference Paper (6)
  7. Guidelines (3)
  8. Correspondence (2)
  9. Book Whole (1)
  10. Miscellaneous (1)
  11. Research Letter (1)
Groups
  1. Department of Medicine (436)
  2. Gastrointestinal Oncology Service (436)
  3. Solid Tumor Oncology Division (436)
  4. Center for Pancreatic Cancer Research (187)
  5. Surgery (137)
  6. Survivorship Research (127)

More Groups

People
  1. David Kelsen (132)
  2. Geoffrey Ku (123)
  3. Yelena Janjigian (112)
  4. Marinela Capanu (65)
  5. Laura Tang (60)
  6. Manjit Bains (51)

More People

Years
  1. 2025 (8)
  2. 2024 (16)
  3. 2023 (24)
  4. 2022 (21)
  5. 2021 (22)
  6. 2020 (20)

More Years

Publications
  1. Journal of Clinical Oncology (135)
  2. Annals of Oncology (28)
  3. International Journal of Radiation Oncology, Biology, Physics (15)
  4. Journal of the National Comprehensive Cancer Network (14)
  5. Annals of Surgical Oncology (13)
  6. Cancer (12)

More Publications

Publishers
  1. American Society of Clinical Oncology (137)
  2. Elsevier Inc. (59)
  3. Oxford University Press (41)
  4. Springer (32)
  5. Lippincott Williams & Wilkins (22)
  6. Wiley Blackwell (19)

More Publishers

Results (436)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The activity of paclitaxel in gastrointestinal tumors
    Conference Paper

    Ajani, J. A.; Ilson, D. H.; Kelsen, D. P.
    Elsevier Inc. (1995)

    Fulltext@MSK | Save
  • Paclitaxel in the treatment of carcinoma of the esophagus
    Conference Paper

    Ajani, J. A.; Ilson, D. H.; Daugherty, K.; Kelsen, D. P.
    Elsevier Inc. (1995)

    Fulltext@MSK | Save
  • Chemotherapy and combined-modality therapy for esophageal cancer
    Conference Paper

    Kelsen, D. P.; Ilson, D. H.
    American College of Chest Physicians (1995)

    Fulltext@MSK | Save
  • A phase II trial of interferon alpha‐2A, 5‐fluorouracil, and cisplatin in patients with advanced esophageal carcinoma
    Journal Article

    Ilson, D. H.; Sirott, M.; Saltz, L.; Heelan, R.; Huang, Y.; Keresztes, R.; Kelsen, D. P.
    Cancer (1995)

    Fulltext@MSK | Save
  • A phase II trial of paclitaxel (Taxol) in advanced esophageal cancer: Preliminary report
    Conference Paper

    Kelsen, D.; Ajani, J.; Ilson, D.; Daugherty, K.; Pazdur, R.
    Elsevier Inc. (1994)

    Fulltext@MSK | Save
  • Combined modality therapy in the treatment of esophageal cancer
    Journal Article

    Ilson, D. H.; Kelsen, D. P.
    Seminars in Oncology (1994)

    Fulltext@MSK | Save
  • Clinical relevance of the I(12p) marker chromosome in germ cell tumors
    Journal Article

    Bosl, G. J.; Ilson, D. H.; Rodriguez, E.; Motzer, R. J.; Reuter, V. E.; Chaganti, R. S. K.
    JNCI: Journal of the National Cancer Institute (1994)

    Fulltext@MSK | Save
  • Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus
    Journal Article

    Ajani, J. A.; Ilson, D. H.; Daugherty, K.; Pazdur, R.; Lynch, P. M.; Kelsen, D. P.
    JNCI: Journal of the National Cancer Institute (1994)

    Fulltext@MSK | Save
  • Taxol-induced soft-tissue injury secondary to extravasation: Characterization by histopathology and clinical course
    Journal Article

    Ajani, J. A.; Dodd, L. G.; Daugherty, K.; Warkentin, D.; Ilson, D. H.
    JNCI: Journal of the National Cancer Institute (1994)

    Fulltext@MSK | Save
  • Phase II trial of topotecan in patients with advanced renal cell carcinoma
    Journal Article

    Murray Law, T.; Ilson, D. H.; Motzer, R. J.
    Investigational New Drugs (1994)

    Fulltext@MSK | Save